683 Capital Management, LLC Expands Stake in Affimed NV
AFMD Stock | USD 2.62 0.02 0.76% |
About 60% of Affimed NV's investor base is looking to short. The analysis of the overall investor sentiment regarding Affimed NV suggests that many traders are alarmed. The current market sentiment, together with Affimed NV's historical and current headlines, can help investors time the market. In addition, many technical investors use Affimed NV stock news signals to limit their universe of possible portfolio assets.
Affimed |
Overview of the Recent Transaction On October 14, 2024, 683 Capital Management, LLC made a significant addition to its investment portfolio
Read at gurufocus.com
Affimed NV Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Affimed NV can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Affimed NV Fundamental Analysis
We analyze Affimed NV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Affimed NV using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Affimed NV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
Affimed NV is currently under evaluation in net asset category among its peers. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Affimed NV Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Affimed NV stock to make a market-neutral strategy. Peer analysis of Affimed NV could also be used in its relative valuation, which is a method of valuing Affimed NV by comparing valuation metrics with similar companies.
Peers
Affimed NV Related Equities
AGEN | Agenus | 16.78 | ||||
PIRS | Pieris Pharmaceuticals | 5.27 | ||||
INZY | Inozyme Pharma | 4.46 | ||||
ADAP | Adaptimmune Therapeutics | 3.13 | ||||
DAWN | Day One | 2.85 | ||||
ADCT | ADC Therapeutics | 2.58 | ||||
TERN | Terns Pharmaceuticals | 1.40 | ||||
MREO | Mereo BioPharma | 1.09 | ||||
CRVS | Corvus Pharmaceuticals | 0.11 | ||||
LPTX | Leap Therapeutics | 1.16 | ||||
ELEV | Elevation Oncology | 1.64 | ||||
HEPA | Hepion Pharmaceuticals | 4.35 | ||||
PDSB | PDS Biotechnology | 5.00 | ||||
XFOR | X4 Pharmaceuticals | 8.11 | ||||
APTO | Aptose Biosciences | 20.83 |
Complementary Tools for Affimed Stock analysis
When running Affimed NV's price analysis, check to measure Affimed NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Affimed NV is operating at the current time. Most of Affimed NV's value examination focuses on studying past and present price action to predict the probability of Affimed NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Affimed NV's price. Additionally, you may evaluate how the addition of Affimed NV to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |